About
Profile
Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
BMY
The bio-pharmaceutical stock jumped 5.3% after the U.S. Food and Drug Administration approved Cobenfy as a treatment of schizophrenia for adults. It marks the first new type of treatment for the mental disorder in several decades.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Bristol-Myers sets below-consensus guidance amid generic competition
- Bristol-Myers Squibb Company Non-GAAP EPS of $1.75 misses by $0.24, revenue of $11.2B misses by $610M
- Bristol-Myers Squibb set to continue streak of EPS beats with Q2 results
- Immatics climbs 8% on $35M investment by Bristol Myers Squibb
- Catalyst Watch: Earnings blitz, central bank meetings, UPS strike jitters and Barbenheimer
- Bristol Myers nabs EU endorsement for Opdivo in melanoma
- J&J becomes latest Big Pharma to sue over Medicare drug pricing
- HSBC bullish on Roche, Lonza; bearish on Bristol-Myers, GSK, Moderna
- Eli Lilly, Merck among top pharma picks in Barclays Q2 preview
- Atrial fibrillation drug market expected to decline as brand therapies go generic
- Bristol Myers succeeds in Phase 3 trial for Opdivo in bladder cancer
- Bristol Myers inks licensing pact under Evotec neuroscience deal
- Bristol gains worldwide license to Prothena Alzheimer's candidate
- Goldman Sachs sees rays of hope in underperforming health sector
- Medicare revises guidance on drug price negotiations amid lawsuits
- Dividend Roundup: General Mills, Mastercard, JPMorgan, Verizon, and more
- Bristol-Myers Squibb wins EC approval of Camzyos for cardiomyopathy
- What is behind big pharma's underperformance?
- Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations
- Bristol Myers reportedly sues over new Medicare drug pricing program
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| February 4, 2022 | 1.83 / 1.8 | 11.99B / 12.09B | |
| October 27, 2021 | 2 / 1.92 | 11.62B / 11.61B |
Beat! |
| July 28, 2021 | 1.93 / 1.89 | 11.7B / 11.27B |
Beat! |
| April 29, 2021 | 1.74 / 1.81 | 11.07B / 11.13B | |
| February 4, 2021 | 1.46 / 1.42 | 11.07B / 10.73B |
Beat! |
| November 5, 2020 | 1.63 / 1.49 | 10.54B / 10.32B |
Beat! |
| August 6, 2020 | 1.63 / 1.48 | 10.13B / 9.99B |
Beat! |
| July 23, 2020 | - / 1.59 | - / 10.4B | |
| May 7, 2020 | 1.72 / 1.49 | 10.78B / 10.03B |
Beat! |
| February 6, 2020 | 1.22 / 0.88 | 7.95B / 7.12B |
Beat! |
| October 31, 2019 | 1.17 / 1.07 | 6.01B / 5.9B |
Beat! |
| July 25, 2019 | 1.18 / 1.07 | 6.27B / 6.11B |
Beat! |
| April 25, 2019 | 1.1 / 1.09 | 5.92B / 5.75B |
Beat! |
| January 24, 2019 | 0.94 / 0.85 | 5.97B / 5.98B | |
| October 25, 2018 | 1.09 / 0.91 | 5.69B / 5.72B | |
| July 26, 2018 | 1.01 / 0.88 | 5.7B / 5.44B |
Beat! |
| April 26, 2018 | 0.94 / 0.85 | 5.19B / 5.25B | |
| February 5, 2018 | 0.68 / 0.67 | 5.45B / 5,353M |
Beat! |
| October 26, 2017 | 0.75 / 0.77 | 5.25B / 5,196M |
Beat! |
| July 27, 2017 | 0.74 / 0.76 | 5.14B / 5.09B |
Beat! |
| April 27, 2017 | 0.84 / 0.73 | 4.93B / - |
Beat! |
| January 26, 2017 | 0.84 / 0.73 | 5.24B / - |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2023 | 56.61 | 56.22 |
57.12
|
55.7
|
8.5M | -0.09% | ||||
| Oct 6, 2023 | 56.66 | 56.25 |
56.88
|
56.17
|
8.9M | 0.43% | ||||
| Oct 5, 2023 | 56.42 | 56.04 |
56.61
|
55.83
|
8.0M | -0.55% | ||||
| Oct 4, 2023 | 56.73 | 57.1 |
57.34
|
56.31
|
11.7M | -0.86% | ||||
| Oct 3, 2023 | 57.22 | 57.66 |
58.05
|
57.12
|
11.0M | -1.09% | ||||
| Oct 2, 2023 | 57.85 | 58.01 |
58.06
|
57.15
|
8.9M | -0.33% | ||||
| Sep 29, 2023 | 58.04 | 58.18 |
58.46
|
57.87
|
10.9M | -0.17% | ||||
| Sep 28, 2023 | 58.14 | 58.01 |
58.42
|
57.81
|
8.3M | 0.43% | ||||
| Sep 27, 2023 | 57.89 | 58.58 |
58.75
|
57.61
|
11.4M | -1.11% | ||||
| Sep 26, 2023 | 58.54 | 58.87 |
59.25
|
58.52
|
9.4M | -1.05% | ||||
| Sep 25, 2023 | 59.16 | 58.84 |
59.28
|
58.55
|
7.0M | 0.44% | ||||
| Sep 22, 2023 | 58.9 | 59.33 |
59.46
|
58.77
|
8.2M | -0.3% | ||||
| Sep 21, 2023 | 59.08 | 58.56 |
59.46
|
58.53
|
9.6M | 0.51% | ||||
| Sep 20, 2023 | 58.78 | 58.8 |
59.31
|
58.71
|
8.7M | 0.26% | ||||
| Sep 19, 2023 | 58.63 | 58.56 |
58.92
|
58.34
|
9.0M | 0.09% | ||||
| Sep 18, 2023 | 58.58 | 59.04 |
59.15
|
58.33
|
14.6M | -0.76% | ||||
| Sep 15, 2023 | 59.03 | 59.44 |
59.83
|
58.86
|
22.4M | -0.77% | ||||
| Sep 14, 2023 | 59.49 | 60.14 |
60.55
|
59.28
|
18.1M | -0.27% | ||||
| Sep 13, 2023 | 59.65 | 60.25 |
60.58
|
59.65
|
18.2M | -0.98% | ||||
| Sep 12, 2023 | 60.24 | 61.01 |
61.01
|
59.84
|
9.7M | -0.94% | ||||
| Sep 11, 2023 | 60.81 | 60.75 |
61.42
|
60.68
|
13.2M | -0.02% | ||||
| Sep 8, 2023 | 60.82 | 60.16 |
60.89
|
60.01
|
9.5M | 1.42% | ||||
| Sep 7, 2023 | 59.97 | 59.87 |
60.5
|
59.85
|
9.3M | 0.50% | ||||
| Sep 6, 2023 | 59.67 | 60.3 |
60.4
|
59.45
|
11.5M | -1.6% | ||||
| Sep 5, 2023 | 60.64 | 61.89 |
62
|
60.59
|
10.8M | -2.23% | ||||
| Sep 1, 2023 | 62.02 | 61.83 |
62.4
|
61.83
|
6.8M | 0.60% | ||||
| Aug 31, 2023 | 61.65 | 62.45 |
62.53
|
61.65
|
11.4M | -1.17% | ||||
| Aug 30, 2023 | 62.38 | 62.93 |
63.03
|
62.2
|
9.0M | -0.75% | ||||
| Aug 29, 2023 | 62.85 | 61.98 |
63.41
|
61.98
|
12.0M | 1.96% | ||||
| Aug 28, 2023 | 61.64 | 62.06 |
62.41
|
61.38
|
6.4M | -0.71% | ||||
| Aug 25, 2023 | 62.08 | 61.42 |
62.3
|
61.25
|
8.0M | 1.31% | ||||
| Aug 24, 2023 | 61.28 | 61.36 |
62.01
|
61.22
|
8.3M | -0.45% | ||||
| Aug 23, 2023 | 61.56 | 62.26 |
62.4
|
61.41
|
7.8M | -0.48% | ||||
| Aug 22, 2023 | 61.86 | 61.81 |
62.13
|
61.6
|
8.5M | -0.08% | ||||
| Aug 21, 2023 | 61.91 | 62.13 |
62.49
|
61.9
|
7.7M | -0.24% | ||||
| Aug 18, 2023 | 62.06 | 62.22 |
62.58
|
61.87
|
8.2M | -0.14% | ||||
| Aug 17, 2023 | 62.15 | 61.01 |
62.72
|
61
|
17.9M | 2% | ||||
| Aug 16, 2023 | 60.93 | 61.34 |
61.62
|
60.88
|
7.9M | -1.33% | ||||
| Aug 15, 2023 | 61.75 | 61.53 |
62.15
|
61.2
|
14.4M | 0.21% | ||||
| Aug 14, 2023 | 61.62 | 61.35 |
61.88
|
61.21
|
16.5M | 0.64% | ||||
| Aug 11, 2023 | 61.23 | 61.53 |
61.73
|
61.07
|
16.8M | -0.1% | ||||
| Aug 10, 2023 | 61.29 | 61.09 |
61.95
|
60.95
|
21.1M | 1.11% | ||||
| Aug 9, 2023 | 60.62 | 59.8 |
60.95
|
59.75
|
7.7M | 0.76% | ||||
| Aug 8, 2023 | 60.16 | 60.69 |
60.82
|
59.71
|
12.5M | -0.51% | ||||
| Aug 7, 2023 | 60.47 | 60.51 |
60.76
|
60.1
|
9.8M | -0.03% | ||||
| Aug 4, 2023 | 60.49 | 61.08 |
61.45
|
60.37
|
7.6M | -1.21% | ||||
| Aug 3, 2023 | 61.23 | 61.46 |
61.47
|
60.45
|
6.7M | -0.84% | ||||
| Aug 2, 2023 | 61.75 | 61.17 |
62.33
|
61.02
|
11.9M | 0.36% | ||||
| Aug 1, 2023 | 61.53 | 62.32 |
62.57
|
61.18
|
9.2M | -1.06% | ||||
| Jul 31, 2023 | 62.19 | 61.35 |
62.32
|
61.11
|
11.7M | 1.27% | ||||
| Jul 28, 2023 | 61.41 | 60.8 |
61.5
|
60.05
|
11.6M | 1.12% | ||||
| Jul 27, 2023 | 60.73 | 61 |
62.53
|
60.38
|
22.6M | -4.23% | ||||
| Jul 26, 2023 | 63.41 | 63.14 |
63.89
|
62.92
|
11.0M | -0.56% | ||||
| Jul 25, 2023 | 63.77 | 64.5 |
64.65
|
63.75
|
7.0M | -1.48% | ||||
| Jul 24, 2023 | 64.73 | 64.7 |
65.38
|
64.7
|
6.9M | 0.08% | ||||
| Jul 21, 2023 | 64.68 | 63.89 |
64.79
|
63.76
|
9.9M | 1.43% | ||||
| Jul 20, 2023 | 63.77 | 62.45 |
64.04
|
62.37
|
9.3M | 2.76% | ||||
| Jul 19, 2023 | 62.06 | 62.12 |
62.86
|
62
|
8.6M | 0.10% | ||||
| Jul 18, 2023 | 62 | 61.94 |
62.76
|
61.8
|
6.4M | 0.24% | ||||
| Jul 17, 2023 | 61.85 | 61.99 |
62.01
|
61.4
|
7.5M | 0% | ||||